Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Blood|January 1, 1994
In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell lineG Zauli, M Vitale, M C Re, et al.
Differentiation; Research in Biological Diversity|March 14, 2009
TRAIL pathway components and their putative role in granulosa cell apoptosis in the human ovaryM Jääskeläinen, A Kyrönlahti, M Anttonen, et al.
Blood|November 1, 1991
In vitro growth and regulation of bone marrow enriched CD34+ hematopoietic progenitors in Diamond-Blackfan anemiaG P Bagnara, G Zauli, L Vitale, et al.
British Journal of Haematology|February 1, 1989
In vivo and in vitro inhibitory effect of alpha-interferon on megakaryocyte colony growth in essential thrombocythaemiaL Gugliotta, G P Bagnara, L Catani, et al.
Blood|September 15, 1994
A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1G Zauli, G Furlini, M Vitale, et al.
Microbiologica|October 1, 1992
Absence of HTLV-I/II infection in blood donors with positive and inconclusive HTLV-I/II serologyM C Re, G Furlini, E Ramazzotti, et al.
AIDS Research and Human Retroviruses|December 5, 1998
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat proteinA Corallini, M Betti, M Rusnati, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 1, 1995
Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivoM C Re, G Furlini, M Vignoli, et al.
Blood|August 26, 1998
Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cellsP Secchiero, L Bertolaso, L Casareto, et al.
Haematologica|July 1, 1992
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemiaL Catani, L Gugliotta, G Zauli, et al.
Pageof 16